SI-BONE Inc (NAS:SIBN)
$ 13.38 -0.43 (-3.11%) Market Cap: 557.87 Mil Enterprise Value: 444.76 Mil PE Ratio: 0 PB Ratio: 3.37 GF Score: 70/100

SI-BONE Inc at 39th Annual J.P. Morgan Healthcare Conference (Virtual) Transcript

Jan 14, 2021 / 07:50PM GMT
Release Date Price: $28.77 (-2.18%)
Jonathan Pham

Good afternoon, and welcome to today's session at the JPMorgan Healthcare Conference with SI-BONE. My name is Jonathan Pham from JPMorgan's Healthcare Investment Banking team, and it is my great pleasure to introduce you to Jeff Dunn, President and CEO; as well as Laura Francis, CFO and CEO -- COO of SI-BONE to kick things off.

Jeffrey W. Dunn
SI-BONE, Inc. - Chairman, President & CEO

Thanks, Jonathan, and thanks, everyone, for attending. I'd like to just jump right into the slides. We'll skip by the safe harbor statement, and I am now on the third slide, starting with transforming and leading the sacropelvic space.

We are addressing a very large market in the sacroiliac joint, which is the largest joint in one's body. It is responsible for about 20% of all lower back pain, and the market is about 279,000 potential procedures per year. We started the company about 13 years ago. We are less than 10% market penetrated, mostly because it took quite a number of years to get through the reimbursement. And now we're in a terrific place, and I'll

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot